Former Johnson & Johnson CEO Alex Gorsky joined in a $60 million series B financing round for Causaly, an artificial intelligence-powered biomedical research company.
Read the full post on Becker's Hospital Review - Healthcare News
Former J&J CEO backs $60M round for AI-powered drug discovery platform
